Food and Drug Administration (FDA) This could include drugs such as semaglutide (the active ingredient in Ozempic and Wegovy), According to the FDAs announcement, the organization is asking for submitted comments for or against this decision by the end of June 2026 before making their final determination
However, the drug regulatory authorities have also documented rare and occasional severe side effects associated with using GLP-1 agonists, especially GI disease
Contact us today for more information about Semaglutide GLP-1 injections or to book an appointment were happy to get started as soon as you are
Conclusions and future perspectives Despite its long history of human use, issues of legality have contributed to significant gaps in our understanding of the efficacy of cannabis in alleviating symptoms of disease and the physiochemical properties of the more 500 chemicals that cannabis produces
The country's drug exports have increased the most in two decades in the fiscal year ending in June, 2025, growing 34% to $457 million, according to the association
JAMA Pediatr 178 , 1307 (2024)